Andrea Grioni is Associate Director in Global Clinical Development at Novartis, based in Basel, working on a large-scale cardiovascular outcomes trial, where he brings a data-driven approach to decision-making and trial oversight. He holds PhDs in translational medicine and in bioinformatics, and spent five years in data science and AI for biomarker discovery at Novartis Biomedical Research before moving into clinical development in 2025. He writes on how data and AI are augmenting the clinical development role.